Abstract
Polycystic Kidney disease is the most common heritable disease in humans. In addition to epithelial cysts in the kidney, liver and pancreas, patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) also suffer from abdominal hernia, intracranial aneurysm, gastrointestinal cysts, and cardiac valvular defects; conditions often associated with altered extracellular matrix production or integrity. Despite more than a decade of work on the principal ADPKD genes, PKD1 and PKD2, questions remain about the basis of cystic disease and the role of extracellular matrix in ADPKD pathology. This review explores the links between Polycystins, focal adhesions, and extracellular matrix gene expression. These relationships suggest roles for Polycystins in cell-matrix mechanosensory signaling that control matrix production and morphogenesis.
Introduction
Mutations in the polycystin genes PKD1 and PKD2 are responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common heritable human disease [1]. The proteins encoded by PKD1 and PKD2 function together as a mechanosensory ion channel complex [2, 3] that controls calcium influx in response to fluid flow [4] or calcium release from intracellular calcium stores [5]. Polycystin-1 is required for Polycystin-2-dependent calcium transients and is thought to stimulate Polycystin-2 channel activity [4]. While the identification of the PKD1 and PKD2 genes as mechanosensors provided important leads in determining the basis of cystic disease [6, 7], the cellular mechanisms maintaining normal tissue architecture that are controlled by Polycystins remain unclear. Most recent studies have focused on a role for polycystins as mechanosensors in primary cilia with good reason. Nearly every cystic disease protein identified in the past ten years, including Polycystin-1 and Polycystin-2, has been shown to localize to the cilium and in some cases directly affect ciliogenesis [8]. The cilia hypothesis of cystic disease in its original form posited that cilia, via the activity of polycystin mechanosensory channels, sense tubule lumen fluid flow; loss of cilia mechanosensory signals due to polycystin mutation uncouples fluid flow from regulation of epithelial cell proliferation or cell orientation and leads directly to tubule lumen distension and cyst formation [4]. The elegant simplicity of this model has been challenged on several fronts in recent years. The unexpected finding that conditional knockout of Polycystins and other cilia associated genes after postnatal day 14 results in very delayed and in some cases non-uniform cyst formation argues against an acute effect of impairs flow sensing [9–11]. The requirement for injury or stress to the kidney for cyst formation in these models has shifted attention to how mutations in cyst genes predispose tubule cells to failed regeneration and tubule repair [10, 11]. It is also perhaps surprising that Polycystin-1-deficient embryonic kidneys do not form cysts when explanted and grown in culture despite the lack of tubule flow and lack of the postulated flow sensor Polycystin-1 [12]. Thus while the genetic evidence for a central role of the primary cilium in cystic disease remains strong, the model of Polycystins as a flow sensors in the cilium may not be sufficient to fully explain Polycystin loss of function phenotypes. This point is made clear by the observation that the consequences of Polycystin-1 loss of function in the kidney is much more severe than the phenotype of kidney “cilia-null” animals. In conditional, kidney-specific Kif3a knockout mice, kidney tubule cells lack cilia and cystic pathology (fusiform dilatations) first appears at post-natal day 5 (P5), with full involvement of the kidney at P35 [13]. In contrast, kidney-specific knockout of Pkd1 using the same Ksp-Cre line produces cystic kidneys at birth with full involvement of the kidney at P12 followed by death between P14 and P17 [14]. These results as well as studies dating back to the 1980’s linking renal and extrarenal ADPKD pathology to alterations in the extracellular matrix, invite a reexamination of Polycystin function.
ADPKD and integrity of the extracellular matrix
The idea that matrix defects or altered cell adhesion contribute to ADPKD pathology arose in the 1980’s with the findings that the extracellular matrix of cystic tissue or cells derived from cysts was dramatically different from normal kidney tubules [15, 16]. Over-production of ECM proteins has been observed in several studies of ADPKD cells [15, 17] and in ADPKD animal models [18–20]. Epithelial cells from cysts also show increased adhesiveness to type I and type IV collagen and decreased migration in response to growth factors [21, 22]. Altered expression of integrin cell adhesion receptor subtypes has also been reported in ADPKD cells [21, 23]. In addition, genes encoding extracellular matrix proteins or cellular proteins involved in adhesion figure prominently in the lists of upregulated mRNAs in expression profiling studies of human cystic tissue and cystic animal models [23–27]. In some cases, changes in matrix adhesion gene expression precede changes in proliferation-associated genes [27].
Direct evidence that mutations in cell adhesion and extracellular matrix genes are sufficient to cause kidney cyst formation can be found in mouse knockout studies. A hypomorphic mouse laminin-5 mutant develops cortical and medullary kidney cysts with persistence of immature laminins (laminin 332) and basement membrane thickening around cystic tubules [28]. Mutations in the focal adhesion complex protein tensin result in a slowly progressive kidney cystic pathology, indicating that weakening of focal adhesions is sufficient to cause cysts [29].
While these findings suggest that Polycystins regulate cell adhesion or matrix composition and that mutations affecting cell adhesion can cause kidney cysts, it has been difficult to assign a primary role for Polycystins in regulating cell-matrix interactions since altered extracellular matrix synthesis is a well known response to tubule distension and tissue inflammation [30], both of which occur in the course of cyst development [31]. To separate Polycystin-associated cyst initiation events from disease progression and consequences of cyst formation requires a more comprehensive analysis of the data.
Extrarenal manifestations of ADPKD and the extracellular matrix
Extrarenal manifestations of ADPKD more directly suggest a link between Polycystin function and extracellular matrix production. ADPKD is strongly associated with intracranial and aortic aneurysm [32, 33]. It is estimated that 8% of all ADPKD patients also have aneurysm, a significantly higher frequency than that in the general population [34]. Aneurysm is a weakening of the blood vessel wall, commonly caused by mutations in extracellular matrix proteins, for example collagen III and fibrillin [35]. The elasticity and adaptation of the aortic wall to pulsatile blood pressure relies on mechanosensitve responses of vascular smooth muscle cells interposed between layers of elastin matrix that confer recoil properties on the vessel wall [36]. Aneurysmal pathology is characterized by increased production and accumulation of matrix proteins between elastin layers, increased proliferation of vascular smooth muscle cells, elastin fragmentation, and ultimately wall thinning leading to rupture and hemorrhage [36]. Significantly, vascular fragility and aneurysm have been modeled in mouse Pkd1 knockout and hypomorphic mutants [37, 38]. In Pkd1 hypomorphs, thickening of the vessel wall media by increased deposition of proteoglycans and fibronectin is the earliest pathology associated with dissecting aneurysm [37]. Hassane et al. propose that loss of Polycystin-1 alters smooth muscle interaction with matrix allowing them to revert to a synthetic phenotype, resulting in overproduction of matrix proteins. This phenotype, as well as earlier work showing persistence of embryonic gene expression in ADPKD cells [39], introduces the idea that polycystins may normally act as negative feedback regulators that promote cell differentiation and downregulate matrix synthesis. Recent studies of Polycystin-deficient vascular smooth muscle cells (VSMC) have implicated Polycystin-1 and Polycystin-2 in mechanosensation of stretch or vessel pressure [40]. In normal VSMC’s, increased lumenal pressure activates stretch activated ion channels in VSMC’s resulting in calcium influx, smooth muscle contraction and a strengthening of the vessel wall that resists further vessel dilation, a response known as the Bayliss effect [41]. Loss of Polycystin-1 or over expression of Polycystin-2 in smooth muscle inhibits activation of stretch activated ion channels that mediate myogenic tone. The implication of this work is that the balance of Polycystin-1 and Polycystin-2 expression can alter the sensitivity of smooth muscle cells to mechanosensory signaling, either by direct interactions with stretch activated channels or indirectly by effects on the cytoskeleton [40]. By modifying how cells respond to stretch [42], mutations in polycystins are likely to have a broad impact on cellular mechanisms regulating synthesis and degradation of vessel wall extracellular matrix [43].
Other less well studied extrarenal pathology associated with ADPKD also suggests a role for polycystins in cell-matrix interactions. ADPKD is associated with increased occurrence of abdominal wall hernia [44]. Structural weakness of the abdominal wall may be associated with residual effects of developmental abnormalities such as failed ventral closure (omphalocoel) or, more commonly in adults, to altered body wall collagen composition [45]. Other extra-renal manifestations of ADPKD that may involve matrix defects include gastrointestinal cysts, cardiac valve defects and pericardial effusion [46, 47].
Overproduction of matrix collagen has also been observed in zebrafish models of Polycystin-1 and Polycystin-2 deficiency [18]. Polycystin knockdown or mutation in zebrafish causes dorsal axis curvature which is linked to over expression collagen mRNAs and protein expression in the notochord. Reducing matrix gene expression by col2a1 knockdown rescues axis curvature defects, suggesting that abnormalities in matrix composition or amount are developmental defects linked directly to Polycystin function and not secondary consequences of tissue damage or inflammation [18]. Persistent expression of notochord collagen genes in Polycystin-deficient embryos further emphasizes a potential role for Polycystins in negative feedback regulation of matrix synthesis that signal completion of morphogenesis. This view of Polycystins as sensors of mature extracellular matrix may be analogous to “outside-in” integrin signaling [48].
Association of Polycystins with focal adhesions and extracellular matrix proteins
Biochemical and Immunolocalization studies have placed Polycystin-1 in multiple cell adhesion structures including focal adhesions, the principle cellular structure mediating cell-matrix adhesion [21, 49–52]. Focal adhesions form when cell-matrix attachment induces clustering of integrin receptors, recruiting multiple structural and signaling molecules to the integrin intracellular C-terminus [53]. Focal adhesion structural proteins include talin, tensin, vinculin and alpha-actinin and signaling proteins include focal adhesion kinase, c-Src, p130cas and paxillin [53]. Focal adhesions also anchor intracellular actin filaments and support assembly of actin stress fibers, key cellular structures mediating not only cell adhesion but also active matrix sensing. Cells actively probe their local environment by both ligation-induced signaling, which depends on cell-matrix biochemical interactions, as well as by traction-induced signaling which depends on cellular force generation between points of cell-matrix contact and mediates cell responses to the rigidity of the extracellular matrix [48, 54]. Focal adhesions also provide a direct path for external forces to generate cell responses to mechanical perturbation. For example, force applied directly to focal adhesion-anchored actin filaments is sufficient to open mechanosensitive stretch-activated ion channels and initiate calcium signaling responses that strengthen local cytoskeletal structure [55]. Several lines of evidence point to a role for Polycystin-1 as an active component of focal adhesions.
Polycystin-1 is localized to focal complexes in both smooth muscle and epithelial cells [52, 56]. In epithelial cells, Polycystin-1 is associated with multiple focal adhesion components including talin, vinculin, p130Cas, FAK, alpha-actinin, paxillin and pp60c-src and is posttranslationally modified by tyrosine phosphorylation, suggesting that Polycystin-1 may regulate or be regulated by cell-matrix interactions [56, 57]. Expression of the Polycystin-1 C-terminus in spreading inner medullary collecting duct cells stimulates phosphorylation of the focal adhesion components focal adhesion kinase and paxillin, and promotes FAK-paxillin association [58]. Conversely, Polycystin-1-deficient cells show reduced spreading and altered migration [21, 58].
In addition to being associated in focal adhesions with matrix-binding integrin receptors, the large N-terminal extracellular domain of Polycystin-1 contains multiple motifs predicted to participate directly in cell adhesion [6]. These include the N-terminal leucine rich repeats (LRR), a C-type lectin domain, and the PKD repeats [6]. An isolated Polycystin-1 LRR domain fusion protein has been shown to bind directly to the matrix proteins collagen I, fibronectin, and laminin, confirming initial structural predictions [59]. C-type lectin protein domains are commonly involved in calcium-dependent carbohydrate binding [60]. The Polycystin-1 C-type lectin domain binds to collagen I and collagen IV in a calcium-dependent fashion, suggesting a potential role for Polycystin-1 matrix binding in vivo [61]. The PKD repeats of Polycystin-1 are structurally related to Ig domains found in other cell adhesion receptors but comprise a distinct domain family [62]. While the function of the Polycystin-1 PKD domain is not known, related PKD domains are present in collagenolytic proteases where they function as binding domains for insoluble collagen [63, 64]. Taken together, the results indicate a role for Polycystin-1 as a matrix binding component of focal adhesion complexes. If so then how might Polycystin-1 differ from integrins and why might polycystins have a unique and essential role in cell-matrix adhesion?
A unique role for Polycystin-1 in focal adhesion complexes most likely relates to its role as a mechanosensory protein. A characteristic feature of many mechanosensory and matrix proteins is a structure based on tandem domain repeats that have the ability to undergo force-regulated conformational changes [65]. Forces applied to mechanosensitive proteins can expose cryptic protein binding sites and phosphorylation sites or induce new enzymatic activity. For example, FRET studies have revealed that repeat structures in the matrix molecule fibronectin may be partially unraveled by cell tension-generated force [66]. When physically stretched, the focal adhesion protein p130cas reveals buried phosphorylation sites subject to phosphorylation by c-Src, facilitating downstream signaling [67]. Polycystin-1 itself can be stretched by physical force [68, 69]. Studies of the Polycystin-1 extracellular domain using force spectroscopy demonstrate that it is dynamically extensible and able to refold when stretch forces are removed [68]. The step-wise unfolding of Polycystin-1 has been linked to the tandemly repeated PKD repeats that unfold sequentially under stretch [68]. The distensibility of Polycystin 1 is modulated by disease-causing mutations and environmental conditions [70, 71] suggesting that force-induced changes in Polycystin-1 structure may be physiologically relevant. While the current data support the idea that Polycystin-1 can function as a flexible and elastic linkage between cells or between cells and the extracellular matrix, future studies will have to accommodate the findings that the entire Polycystin-1 extracellular domain is autocatalytically cleaved from its transmembrane spanning domains and that cleavage is required for at least some of Polycystin-1 post-natal functions [72].
Polycystins, matrix sensing and development
Cell adhesion based mechanosensors play a prominent role in development [53, 73]. Epithelial cells require 3-D matrix attachments to complete differentiation and can sense the rigidity of their environment and respond in context dependent ways [74–79]. ADPKD cells often exhibit a partially “de-differentiated” phenotype, suggesting that disease causing mutations in polycystins allow cells to revert to embryonic patterns of gene expression [3]. For instance, embryonic matrix genes and receptors (collagens type I, III, IV, laminins and heparan sulfate proteoglycan, β4 integrin), cell surface proteins (erb-B2, β2 NaK ATPase subunit), and secreted proteins (periostin) are re-expressed in ADPKD tissue, suggesting that ADPKD cells fail to complete an important developmental transition or revert to an immature state [20, 23, 39, 80, 81]. In this view, Polycystins are likely to act as sensors of tubule development and tissue maturation that interact with the cellular environment and adjust gene expression programs to ensure orderly morphogenesis [82]. Future studies of how mechanosensory functions of polycystins may be linked to sensing and production of extracellular matrix are likely to yield fruitful insights in the pathology of ADPKD.
Acknowledgments
I thank members of my laboratory for constructive insights into this work and apologize to others whose work was not cited due to contraints on space and time. I.A.D. is supported by grants DK053093 and DK054711 from the NIH and grants from the the PKD foundation.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–337. doi: 10.1146/annurev.med.60.101707.125712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature. 2000;408:990–994. doi: 10.1038/35050128. [DOI] [PubMed] [Google Scholar]
- 3.Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med. 2003;141:91–101. doi: 10.1067/mlc.2003.13. [DOI] [PubMed] [Google Scholar]
- 4.Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129–137. doi: 10.1038/ng1076. [DOI] [PubMed] [Google Scholar]
- 5.Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol. 2002;4:191–197. doi: 10.1038/ncb754. [DOI] [PubMed] [Google Scholar]
- 6.Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995;10:151–160. doi: 10.1038/ng0695-151. [DOI] [PubMed] [Google Scholar]
- 7.Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272:1339–1342. doi: 10.1126/science.272.5266.1339. [DOI] [PubMed] [Google Scholar]
- 8.Yoder BK. Role of primary cilia in the pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2007;18:1381–1388. doi: 10.1681/ASN.2006111215. [DOI] [PubMed] [Google Scholar]
- 9.Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol. 2007;17:1586–1594. doi: 10.1016/j.cub.2007.08.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Takakura A, Contrino L, Beck AW, Zhou J. Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol. 2008;19:2351–2363. doi: 10.1681/ASN.2007101139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Patel V, Li L, Cobo-Stark P, Shao X, Somlo S, Lin F, Igarashi P. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet. 2008;17:1578–1590. doi: 10.1093/hmg/ddn045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Natoli TA, Gareski TC, Dackowski WR, Smith L, Bukanov NO, Russo RJ, Husson H, Matthews D, Piepenhagen P, Ibraghimov-Beskrovnaya O. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am J Physiol Renal Physiol. 2008;294:F73–83. doi: 10.1152/ajprenal.00362.2007. [DOI] [PubMed] [Google Scholar]
- 13.Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LS, Somlo S, Igarashi P. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci U S A. 2003;100:5286–5291. doi: 10.1073/pnas.0836980100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, Mitobe M, Louvi A, Velazquez H, Ishibe S, Cantley LG, Igarashi P, Somlo S. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet. 2008;17:1505–1516. doi: 10.1093/hmg/ddn039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wilson PD, Hreniuk D, Gabow PA. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol. 1992;150:360–369. doi: 10.1002/jcp.1041500220. [DOI] [PubMed] [Google Scholar]
- 16.Cuppage FE, Huseman RA, Chapman A, Grantham JJ. Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int. 1980;17:372–381. doi: 10.1038/ki.1980.43. [DOI] [PubMed] [Google Scholar]
- 17.Candiano G, Gusmano R, Altieri P, Bertelli R, Ginevri F, Coviello DA, Sessa A, Caridi G, Ghiggeri GM. Extracellular matrix formation by epithelial cells from human polycystic kidney cysts in culture. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;63:1–9. doi: 10.1007/BF02899238. [DOI] [PubMed] [Google Scholar]
- 18.Mangos S, Lam PY, Zhao A, Liu Y, Mudumana S, Vasilyev A, Liu A, Drummond IA. The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation. Dis Model Mech. 2010;3:354–365. doi: 10.1242/dmm.003194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schafer K, Bader M, Gretz N, Oberbaumer I, Bachmann S. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease. Exp Nephrol. 1994;2:190–195. [PubMed] [Google Scholar]
- 20.Ebihara I, Nakamura T, Takahashi T, Yamamoto M, Tomino Y, Nagao S, Takahashi H, Koide H. Altered extracellular matrix component gene expression in murine polycystic kidney. Renal Physiol Biochem. 1995;18:73–80. doi: 10.1159/000173902. [DOI] [PubMed] [Google Scholar]
- 21.Wilson PD, Geng L, Li X, Burrow CR. The PKD1 gene product, “polycystin-1,” is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab Invest. 1999;79:1311–1323. [PubMed] [Google Scholar]
- 22.Wilson PD. Polycystic kidney disease. The New England journal of medicine. 2004;350:151–164. doi: 10.1056/NEJMra022161. [DOI] [PubMed] [Google Scholar]
- 23.Joly D, Morel V, Hummel A, Ruello A, Nusbaum P, Patey N, Noel LH, Rousselle P, Knebelmann B. Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am J Pathol. 2003;163:1791–1800. doi: 10.1016/s0002-9440(10)63539-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Husson H, Manavalan P, Akmaev VR, Russo RJ, Cook B, Richards B, Barberio D, Liu D, Cao X, Landes GM, Wang CJ, Roberts BL, Klinger KW, Grubman SA, Jefferson DM, Ibraghimov-Beskrovnaya O. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics. 2004;84:497–510. doi: 10.1016/j.ygeno.2004.03.009. [DOI] [PubMed] [Google Scholar]
- 25.Lee JE, Park MH, Park JH. The gene expression profile of cyst epithelial cells in autosomal dominant polycystic kidney disease patients. J Biochem Mol Biol. 2004;37:612–617. doi: 10.5483/bmbrep.2004.37.5.612. [DOI] [PubMed] [Google Scholar]
- 26.Riera M, Burtey S, Fontes M. Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism. Kidney Int. 2006;69:1558–1563. doi: 10.1038/sj.ki.5000309. [DOI] [PubMed] [Google Scholar]
- 27.Koupepidou P, Felekkis KN, Kranzlin B, Sticht C, Gretz N, Deltas C. Cyst formation in the PKD2 (1–703) transgenic rat precedes deregulation of proliferation-related pathways. BMC Nephrol. 2010;11:23. doi: 10.1186/1471-2369-11-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Shannon MB, Patton BL, Harvey SJ, Miner JH. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J Am Soc Nephrol. 2006;17:1913–1922. doi: 10.1681/ASN.2005121298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lo SH, Yu QC, Degenstein L, Chen LB, Fuchs E. Progressive kidney degeneration in mice lacking tensin. J Cell Biol. 1997;136:1349–1361. doi: 10.1083/jcb.136.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Quinlan MR, Docherty NG, Watson RW, Fitzpatrick JM. Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction. Am J Physiol Renal Physiol. 2008;295:F1–F11. doi: 10.1152/ajprenal.00576.2007. [DOI] [PubMed] [Google Scholar]
- 31.Martinez JR, Grantham JJ. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis Mon. 1995;41:693–765. doi: 10.1016/s0011-5029(05)80007-0. [DOI] [PubMed] [Google Scholar]
- 32.Biagini A, Maffei S, Baroni M, Piacenti M, Terrazzi M, Paoli F, Trianni G, Picano E, Salvatore L. Familiar clustering of aortic dissection in polycystic kidney disease. Am J Cardiol. 1993;72:741–742. doi: 10.1016/0002-9149(93)90896-k. [DOI] [PubMed] [Google Scholar]
- 33.van Dijk MA, Chang PC, Peters DJ, Breuning MH. Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. J Am Soc Nephrol. 1995;6:1670–1673. doi: 10.1681/ASN.V661670. [DOI] [PubMed] [Google Scholar]
- 34.Gibbs GF, Huston J, 3rd, Qian Q, Kubly V, Harris PC, Brown RD, Jr, Torres VE. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int. 2004;65:1621–1627. doi: 10.1111/j.1523-1755.2004.00572.x. [DOI] [PubMed] [Google Scholar]
- 35.Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN. Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol. 2003;35:1341–1360. doi: 10.1016/s1357-2725(03)00043-8. [DOI] [PubMed] [Google Scholar]
- 36.El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol. 2009;6:771–786. doi: 10.1038/nrcardio.2009.191. [DOI] [PubMed] [Google Scholar]
- 37.Hassane S, Claij N, Lantinga-van Leeuwen IS, Van Munsteren JC, Van Lent N, Hanemaaijer R, Breuning MH, Peters DJ, DeRuiter MC. Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arteriosclerosis, thrombosis, and vascular biology. 2007;27:2177–2183. doi: 10.1161/ATVBAHA.107.149252. [DOI] [PubMed] [Google Scholar]
- 38.Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A. 2000;97:1731–1736. doi: 10.1073/pnas.040550097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ebihara I, Killen PD, Laurie GW, Huang T, Yamada Y, Martin GR, Brown KS. Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease. Lab Invest. 1988;58:262–269. [PubMed] [Google Scholar]
- 40.Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Lauritzen I, Arhatte M, Jodar M, Dedman A, Chatelain FC, Schulte U, Retailleau K, Loufrani L, Patel A, Sachs F, Delmas P, Peters DJ, Honore E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell. 2009;139:587–596. doi: 10.1016/j.cell.2009.08.045. [DOI] [PubMed] [Google Scholar]
- 41.Voets T, Nilius B. TRPCs, GPCRs and the Bayliss effect. Embo J. 2009;28:4–5. doi: 10.1038/emboj.2008.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Morel N, Vandenberg G, Ahrabi AK, Caron N, Desjardins F, Balligand JL, Horie S, Devuyst O. PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflugers Arch. 2008 doi: 10.1007/s00424-008-0561-y. [DOI] [PubMed] [Google Scholar]
- 43.Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech. 2007;40:947–960. doi: 10.1016/j.jbiomech.2006.04.011. [DOI] [PubMed] [Google Scholar]
- 44.Morris-Stiff G, Coles G, Moore R, Jurewicz A, Lord R. Abdominal wall hernia in autosomal dominant polycystic kidney disease. The British journal of surgery. 1997;84:615–617. [PubMed] [Google Scholar]
- 45.Henriksen NA, Yadete DH, Sorensen LT, Agren MS, Jorgensen LN. Connective tissue alteration in abdominal wall hernia. The British journal of surgery. 2010 doi: 10.1002/bjs.7339. [DOI] [PubMed] [Google Scholar]
- 46.Qian Q, Hartman RP, King BF, Torres VE. Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007;2:1223–1227. doi: 10.2215/CJN.01920507. [DOI] [PubMed] [Google Scholar]
- 47.Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. Echocardiographic findings in autosomal dominant polycystic kidney disease. The New England journal of medicine. 1988;319:907–912. doi: 10.1056/NEJM198810063191404. [DOI] [PubMed] [Google Scholar]
- 48.Arnaout MA, Mahalingam B, Xiong JP. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol. 2005;21:381–410. doi: 10.1146/annurev.cellbio.21.090704.151217. [DOI] [PubMed] [Google Scholar]
- 49.Scheffers MS, van der Bent P, Prins F, Spruit L, Breuning MH, Litvinov SV, de Heer E, Peters DJ. Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet. 2000;9:2743–2750. doi: 10.1093/hmg/9.18.2743. [DOI] [PubMed] [Google Scholar]
- 50.Xu GM, Sikaneta T, Sullivan BM, Zhang Q, Andreucci M, Stehle T, Drummond I, Arnaout MA. Polycystin-1 interacts with intermediate filaments. J Biol Chem. 2001;276:46544–46552. doi: 10.1074/jbc.M107828200. [DOI] [PubMed] [Google Scholar]
- 51.Grimm DH, Cai Y, Chauvet V, Rajendran V, Zeltner R, Geng L, Avner ED, Sweeney W, Somlo S, Caplan MJ. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J Biol Chem. 2003;278:36786–36793. doi: 10.1074/jbc.M306536200. [DOI] [PubMed] [Google Scholar]
- 52.Qian Q, Li M, Cai Y, Ward CJ, Somlo S, Harris PC, Torres VE. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol. 2003;14:2280–2287. doi: 10.1097/01.asn.0000080185.38113.a3. [DOI] [PubMed] [Google Scholar]
- 53.Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta. 2004;1692:103–119. doi: 10.1016/j.bbamcr.2004.04.007. [DOI] [PubMed] [Google Scholar]
- 54.Giannone G, Sheetz MP. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol. 2006;16:213–223. doi: 10.1016/j.tcb.2006.02.005. [DOI] [PubMed] [Google Scholar]
- 55.Hayakawa K, Tatsumi H, Sokabe M. Actin stress fibers transmit and focus force to activate mechanosensitive channels. J Cell Sci. 2008;121:496–503. doi: 10.1242/jcs.022053. [DOI] [PubMed] [Google Scholar]
- 56.Wilson PD, Burrow CR. Cystic diseases of the kidney: role of adhesion molecules in normal and abnormal tubulogenesis. Exp Nephrol. 1999;7:114–124. doi: 10.1159/000020592. [DOI] [PubMed] [Google Scholar]
- 57.Geng L, Burrow CR, Li HP, Wilson PD. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta. 2000;1535:21–35. doi: 10.1016/s0925-4439(00)00079-x. [DOI] [PubMed] [Google Scholar]
- 58.Joly D, Ishibe S, Nickel C, Yu Z, Somlo S, Cantley LG. The polycystin 1-C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells. J Biol Chem. 2006;281:26329–26339. doi: 10.1074/jbc.M601373200. [DOI] [PubMed] [Google Scholar]
- 59.Malhas AN, Abuknesha RA, Price RG. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J Am Soc Nephrol. 2002;13:19–26. doi: 10.1681/ASN.V13119. [DOI] [PubMed] [Google Scholar]
- 60.Drickamer K, Taylor ME. Biology of animal lectins. Annu Rev Cell Biol. 1993;9:237–264. doi: 10.1146/annurev.cb.09.110193.001321. [DOI] [PubMed] [Google Scholar]
- 61.Weston BS, Bagneris C, Price RG, Stirling JL. The polycystin-1 C-type lectin domain binds carbohydrate in a calcium-dependent manner, and interacts with extracellular matrix proteins in vitro. Biochim Biophys Acta. 2001;1536:161–176. doi: 10.1016/s0925-4439(01)00046-1. [DOI] [PubMed] [Google Scholar]
- 62.Bycroft M, Bateman A, Clarke J, Hamill SJ, Sandford R, Thomas RL, Chothia C. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. Embo J. 1999;18:297–305. doi: 10.1093/emboj/18.2.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Zhao GY, Chen XL, Zhao HL, Xie BB, Zhou BC, Zhang YZ. Hydrolysis of insoluble collagen by deseasin MCP-01 from deep-sea Pseudoalteromonas sp. SM9913: collagenolytic characters, collagen-binding ability of C-terminal polycystic kidney disease domain, and implication for its novel role in deep-sea sedimentary particulate organic nitrogen degradation. J Biol Chem. 2008;283:36100–36107. doi: 10.1074/jbc.M804438200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wang YK, Zhao GY, Li Y, Chen XL, Xie BB, Su HN, Lv YH, He HL, Liu H, Hu J, Zhou BC, Zhang YZ. Mechanistic insight into the function of the C-terminal PKD domain of the collagenolytic serine protease deseasin MCP-01 from deep sea Pseudoalteromonas sp. SM9913: binding of the PKD domain to collagen results in collagen swelling but does not unwind the collagen triple helix. J Biol Chem. 2010;285:14285–14291. doi: 10.1074/jbc.M109.087023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Vogel V. Mechanotransduction involving multimodular proteins: converting force into biochemical signals. Annu Rev Biophys Biomol Struct. 2006;35:459–488. doi: 10.1146/annurev.biophys.35.040405.102013. [DOI] [PubMed] [Google Scholar]
- 66.Baneyx G, Baugh L, Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci U S A. 2002;99:5139–5143. doi: 10.1073/pnas.072650799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sawada Y, Tamada M, Dubin-Thaler BJ, Cherniavskaya O, Sakai R, Tanaka S, Sheetz MP. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell. 2006;127:1015–1026. doi: 10.1016/j.cell.2006.09.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Qian F, Wei W, Germino G, Oberhauser A. The nanomechanics of polycystin-1 extracellular region. J Biol Chem. 2005;280:40723–40730. doi: 10.1074/jbc.M509650200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Forman JR, Qamar S, Paci E, Sandford RN, Clarke J. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J Mol Biol. 2005;349:861–871. doi: 10.1016/j.jmb.2005.04.008. [DOI] [PubMed] [Google Scholar]
- 70.Ma L, Xu M, Forman JR, Clarke J, Oberhauser AF. Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains. J Biol Chem. 2009;284:32942–32949. doi: 10.1074/jbc.M109.021832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ma L, Xu M, Oberhauser AF. Naturally occurring osmolytes modulate the nanomechanical properties of polycystic kidney disease domains. J Biol Chem. 2010;285:38438–38443. doi: 10.1074/jbc.M110.183913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Wei W, Hackmann K, Xu H, Germino G, Qian F. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J Biol Chem. 2007;282:21729–21737. doi: 10.1074/jbc.M703218200. [DOI] [PubMed] [Google Scholar]
- 73.Wozniak MA, Chen CS. Mechanotransduction in development: a growing role for contractility. Nat Rev Mol Cell Biol. 2009;10:34–43. doi: 10.1038/nrm2592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Kim TJ, Seong J, Ouyang M, Sun J, Lu S, Hong JP, Wang N, Wang Y. Substrate rigidity regulates Ca2+ oscillation via RhoA pathway in stem cells. J Cell Physiol. 2009;218:285–293. doi: 10.1002/jcp.21598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Wei WC, Hsu YC, Chiu WT, Wang CZ, Wu CM, Wang YK, Shen MR, Tang MJ. Low substratum rigidity of collagen gel promotes ERK phosphorylation via lipid raft to augment cell migration. Journal of cellular biochemistry. 2008;103:1111–1124. doi: 10.1002/jcb.21482. [DOI] [PubMed] [Google Scholar]
- 76.Guo WH, Frey MT, Burnham NA, Wang YL. Substrate rigidity regulates the formation and maintenance of tissues. Biophys J. 2006;90:2213–2220. doi: 10.1529/biophysj.105.070144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wang YK, Wang YH, Wang CZ, Sung JM, Chiu WT, Lin SH, Chang YH, Tang MJ. Rigidity of collagen fibrils controls collagen gel-induced down-regulation of focal adhesion complex proteins mediated by alpha2beta1 integrin. J Biol Chem. 2003;278:21886–21892. doi: 10.1074/jbc.M300092200. [DOI] [PubMed] [Google Scholar]
- 78.Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J. 2000;79:144–152. doi: 10.1016/S0006-3495(00)76279-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol. 2003;163:583–595. doi: 10.1083/jcb.200305010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Wallace DP, Quante MT, Reif GA, Nivens E, Ahmed F, Hempson SJ, Blanco G, Yamaguchi T. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am J Physiol Renal Physiol. 2008;295:F1463–1471. doi: 10.1152/ajprenal.90266.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Haverty TP, Neilson EG. Basement membrane gene expression in polycystic kidney disease. Lab Invest. 1988;58:245–248. [PubMed] [Google Scholar]
- 82.Bissler JJ, Dixon BP. A mechanistic approach to inherited polycystic kidney disease. Pediatr Nephrol. 2005;20:558–566. doi: 10.1007/s00467-004-1665-z. [DOI] [PubMed] [Google Scholar]